Patents by Inventor Peter Hankofer

Peter Hankofer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5571664
    Abstract: A negatively developing color photographic silver halide material containing at least two blue-sensitive, yellow-coupling silver halide emulsion layers, at least two green-sensitive, magenta-coupling silver halide emulsion layers, at least two red-sensitive, cyan-coupling silver halide emulsion layers and a yellow filter layer on a transparent support, the layers of the same spectral sensitivity having different photographic sensitivities and the blue-sensitive layers being arranged further from the support than the yellow filter layer and the green-sensitive and red-sensitive layers being arranged nearer the support than the yellow filter layer, is distinguished by improved development kinetics if at least one of the green-sensitive layers of highest sensitivity and the red-sensitive layers of highest sensitivity contains a crown ether.
    Type: Grant
    Filed: September 8, 1995
    Date of Patent: November 5, 1996
    Assignee: Agfa-Gevaert AG
    Inventors: J org Siegel, Peter Hankofer, Hans-Ulrich Borst
  • Patent number: 5238955
    Abstract: Antitumor acting platinum(II or IV) complexes of the general formula ##STR1## where B represents a phenyl-C.sub.1 -C.sub.4 -alkyl radical which is optionally substituted in the phenyl nucleus by the radical R.sub.1 and R.sub.1 is hydrogen, halogen, trihalogen methyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy or C.sub.2 -C.sub.6 -alkanoyloxy or where B together with the structural part H.sub.2 N-CR.sub.2 < forms a tetrahydroisoquinoline radical, if B contains benzyl and R.sub.2 hydrogen and the benzyl radical in the 2-position contains the CH.sub.2 -radical or where B together with the structural part --CR.sub.2 < represents a tetrahydronaphthyl radical in which one CH.sub.2 group is optionally replaced by oxygen, or where B together with the structural part --CR.sub.2 < represents a decahydronaphthyl radical or an indanyl radical; R.sub.2 represents hydrogen, C.sub.1 -C.sub.6 -alkyl, phenyl or phenyl-C.sub.1 -C.sub.4 -alkyl, it also being possible for the phenyl ring of this group R.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: August 24, 1993
    Assignee: Asta Pharma AG
    Inventors: Henri Brunner, Peter Hankofer, Friedrich Maiterth, Jurgen Engel, Wolfgang Schumacher, Peter Hilgard, Rainer Voegeli
  • Patent number: 5194644
    Abstract: Antitumor acting platinum(II or IV) complexes of the general formula ##STR1## where B represents a phenyl-C.sub.1 -C.sub.4 -alkyl radical which is optionally substituted in the phenyl nucleus by the radical R.sub.1 and R.sub.1 is hydrogen, halogen, trihalogen methyl, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy or C.sub.2 -C.sub.6 -alkanoyloxy or where B together with the structural part H.sub.2 N--CR.sub.2 <forms a tetrahydroisoquinoline radical, if B contains benzyl and R.sub.2 hydrogen and the benzyl radical in the 2-position contains the CH.sub.2 -radical or where B together with the structural part --CR.sub.2 < represents a tetrahydronaphthyl radical in which one CH.sub.2 group is optionally replaced by oxygen, or where B together with the structural part --CR.sub.2 < represents a decahydronaphthyl radical or an indanyl radical; R.sub.2 represents hydrogen, C.sub.1 -C.sub.6 -alkyl, phenyl or phenyl-C.sub.1 -C.sub.4 -alkyl, it also being possible for the phenyl ring of this group R.
    Type: Grant
    Filed: April 10, 1991
    Date of Patent: March 16, 1993
    Assignee: Asta Pharma AG
    Inventors: Henri Brunner, Peter Hankofer, Friedrich Maiterth, Jurgen Engel, Wolfgang Schumacher, Peter Hilgard, Rainer Voegeli